HIV-positive individuals being released from prison can have difficulty with adherence to highly active antiretroviral therapy (HAART). This supports the need for programs to improve medication adherence. This study explored the perceived acceptability of HIV directly observed therapy (DOT) among 25 HIV-positive individuals with a history of incarceration. Study subjects were recruited from an urban, hospital-based HIV clinic and completed an interviewer-administered questionnaire. Eighty-four percent felt that DOT would help them in some way and 76% would consider participating in a DOT program. Potential barriers to DOT included frequency of visits and meeting place.
Get full access to this article
View all access options for this article.
References
1.
Alvarez, M. T., SolerA., & RibelliM. (2002). Assessment of directly observed therapy in HIV-infected patients with difficult treatment adherence. XIV International AIDS Conference.
2.
ClarkeS., KeenanE., RyanM., BarryM., & MulcahyF. (2002). Directly observed antiretroviral therapy for injection drug users with HIV infection. AIDS Reader, 12(7), 305-307, 312-316.
3.
FarmerP., LeandreF., MukherjeeJ., GuptaR., TarterL., & Kim, J. Y. (2001). Community-based treatment of advanced HIV disease: Introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy). Bulletin of the World Health Organization, 79(12), 1145-1151.
4.
FlaniganT., Bury-MaynardD., VigilanteK., BursinskyJ., BublyG., KimJ., et al. (1995). Progress and challenges in linking incarcerated individuals with HIV/AIDS to community services. Washington, DC: U.S. Department of Human Services.
5.
Flanigan, T. P., Kim, J. Y., ZierlerS., RichJ., VigilanteK., & Bury-MaynardD. (1996). A prison release program for HIV-positive women: Linking them to health services and community follow-up. American Journal of Public Health, 86(6), 886-887.
6.
FogartyL., RoterD., LarsonS., BurkeJ., GillespieJ., & LevyR. (2002). Patient adherence to HIV medication regimens: A review of published and abstract reports. Patient Education and Counseling, 46, 93-108.
7.
FreudenbergN. (2001). Jails, prisons, and the health of urban populations: A review of the impact of the correctional system on community health. Journal of Urban Health, 78(2), 214-233.
8.
GrossM., RhodesW., ConlyC., EnosT., MasonT., & TruittL. (1995, June). Case management for HIV prevention among drug-involved arrestees. Washington, DC: U.S. Department of Human Services.
9.
Hammett, T. M., Harmon, M. P., & RhodesW. (2002). The burden of infectious disease among inmates of and releasees from U.S. correctional facilities, 1997. American Journal of Public Health, 92(11), 1789-1793.
10.
Mitty, J. A., Stone, V. E., SandsM., MacalinoG., & FlaniganT. (2002). Directly observed therapy for the treatment of people with human immunodeficiency virus infection: A work in progress. Clinical Infectious Diseases, 34, 984-990.
11.
Rich, J. D., HolmesL., SalasC., MacalinoG., DavisD., RyczekJ., et al. (2001). Successful linkage of medical care and community services for HIV-positive offenders being released from prison. Journal of Urban Health, 78(2), 279-289.
12.
Richie, B. E., FreudenbergN., & PageJ. (2001). Reintegrating women leaving jail into urban communities: A description of a model program. Journal of Urban Health, 78(2): 290-303.
13.
StephensonB., WohlD., KiziahN., RosenD., NgoB., MerrimanN., et al. (2002). Release from prison is associated with increased HIVRNA at time of re-incarceration. Paper presented at the 13th International AIDS Conference, Durban, South Africa. Available at http://www.aegis.com/conferences/13WAC
14.
Wohl, D. A., ShainL., AdamianM., Stephenson, B. L., StraussR., GolinC., et al. (2003). HIV transmission risk behaviors among HIV-infected individuals releasedfrom prison. Paper presented at the 10th Conference on Retroviruses and Opportunistic Infections, Boston, MA. Available at http://www.retroconference.org/2003
